Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2013 by Stanford University.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Johns Hopkins University
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01146054
First received: June 15, 2010
Last updated: August 19, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)